ReIMAGINE Prostate Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

July 30, 2021

Study Completion Date

September 30, 2021

Conditions
Prostate Cancer ScreeningProstate Cancer
Interventions
PROCEDURE

Magnetic Resonance Imaging (MRI)

Prostate cancer screening MRI

PROCEDURE

Prostate-specific antigen (PSA) test

Blood test for PSA levels

Trial Locations (1)

NW1 2PG

University College London Hospital, London

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Cancer Research UK

OTHER

collaborator

Imperial College London

OTHER

collaborator

King's College London

OTHER

lead

University College, London

OTHER

NCT04063566 - ReIMAGINE Prostate Cancer Screening | Biotech Hunter | Biotech Hunter